Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113845436B reveals a metal-free photocatalytic method for defluorination, offering cost reduction and scalable synthesis for high-purity fluorinated intermediates.
Patent CN110256365B reveals a green dichlorotitanocene-catalyzed route for benzodiazepines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115557900A details a mild Rh-catalyzed route to 3-substituted pyridazines with quaternary centers, offering high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN101824038B details a high-yield Pd/C and iodine-catalyzed route for camptothecin analogues, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110194724B introduces diphenylmethane carriers for peptide synthesis, offering high purity, simplified extraction, and scalable manufacturing for reliable pharmaceutical intermediate supply.
Patent CN108409743A details mild oxidative cyclization using oxygen. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable intermediates.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.
Patent CN108947945A reveals non-metal catalyzed synthesis offering high yield and mild conditions for fluorescent probe intermediates supply chain optimization.
Patent CN112574090A reveals a metal-free synthesis of sulfur-containing pyrroles. This method offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel patent CN118184591A offers cost-effective synthesis for TYK2 inhibitor intermediates with high purity and scalable processes for global supply chains.
Patent CN115215810B reveals catalyst-free heating method. Reduces cost and supply chain risk for pharma intermediates. High purity and scalability.
Novel metal-free sulfur-promoted method for high-purity triazole intermediates. Reduces cost and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN111978265B reveals a robust FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel sulfur-mediated cyclization offers cost-effective route for high-purity API intermediates. Eliminates heavy metals for scalable commercial production.
Novel Pd-catalyzed pathway reduces costs for chroman amides. Enhances supply chain stability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed synthesis method for isoquinoline ketones offering high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Patent CN113307790B reveals a metal-free oxidative cyclization for 1,2,4-triazoles. Achieve up to 97% yield with scalable, cost-effective manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN113105402B details a novel iodine-promoted synthesis of 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharma manufacturing.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.